Photo by sirsimo from unsplash
Published in this issue of Indian Journal of Ophthalmology is a retrospective cohort of 24 infants with posterior zone 1 or ‘zone half’ aggressive posterior retinopathy of prematurity (APROP) who… Click to show full abstract
Published in this issue of Indian Journal of Ophthalmology is a retrospective cohort of 24 infants with posterior zone 1 or ‘zone half’ aggressive posterior retinopathy of prematurity (APROP) who underwent intravitreal ranibizumab followed by laser photoablation between days 24 and 34 after the injection.[1] They report a 93% favourable outcome after 6 months of follow‐up. The rationale of combining treatments is to possibly synergise the effect of the blocking action of anti‐vascular endothelial growth factor (VEGF) agents with the suppression of production of VEGF as well as to aid elimination of these proangiogenic factors by laser ablation.
Journal Title: Indian Journal of Ophthalmology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!